Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

NCT05112549 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT05112549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05112549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
Lead sponsor
University Hospital Tuebingen
Phase
Phase 1
Overall status
Recruiting
Start date
October 12, 2021
Completion date
September 30, 2027
Enrollment
46 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

leptomeningeal disease